The Bundessortenamt (German Plant Variety Office) approved the application of the Institute of Grapevine Breeding at Hochschule Geisenheim University and registered the grapevine variety Red Riesling on January 18, 2018.
The Institute of Grapevine Breeding at Hochschule Geisenheim University has been breeding the variety Red Riesling since 1991. The application for registration was filed at the Bundessortenamt in 2014. Growers interested in planting the variety can now choose from the following clones: 3 Gm, 4 Gm, 16 Gm, 40 Gm and 42 Gm. Red Riesling was already classified for planting and wine production in the State of Hessen in 2003, and has since then been successfully grown, mostly in this region.
With the entry in the Federal Plant Variety Register, the variety will also be classified for the production of quality wine in all wine growing regions of Rheinland Pfalz. For its planting, no application for a cultivation trial is required and the planting area is no longer restricted. For growers who have planted the variety as a variety cultivation trial, all stipulations associated with the requirements of the trial approval are waived.
The Institute of Grapevine Breeding at Hochschule Geisenheim University has been breeding the variety Red Riesling since 1991. The application for registration was filed at the Bundessortenamt in 2014. Growers interested in planting the variety can now choose from the following clones: 3 Gm, 4 Gm, 16 Gm, 40 Gm and 42 Gm. Red Riesling was already classified for planting and wine production in the State of Hessen in 2003, and has since then been successfully grown, mostly in this region.
With the entry in the Federal Plant Variety Register, the variety will also be classified for the production of quality wine in all wine growing regions of Rheinland Pfalz. For its planting, no application for a cultivation trial is required and the planting area is no longer restricted. For growers who have planted the variety as a variety cultivation trial, all stipulations associated with the requirements of the trial approval are waived.
